Decompensated Liver Failure and Acute Renal Failure in a Patient with Chronic HBV,HCV, and HIV Infections

Year : 2025 | Volume : 02 | Issue : 01 | Page : 17 23
    By

    Devesh Sharma,

  • Saumya Singh,

  • Brijnandan Singh,

  • Nandlal kumar,

  • Rajan pathak,

  1. Professor, Department of Microbiology, United Institute of Medical Sciences, Prayagraj, Uttar Pradesh, India
  2. Professor & Head, Department of Microbiology, United Institute of Medical Sciences, Prayagraj, Uttar Pradesh, India
  3. Assistant Professor, Department of Microbiology, United Institute of Medical Sciences, Prayagraj, Uttar Pradesh, India
  4. Assistant Professor, Department of Microbiology, United Institute of Medical Sciences, Prayagraj, Uttar Pradesh, India
  5. Senior Resident, Department of Microbiology, United Institute of Medical Sciences, Prayagraj, Uttar Pradesh, India

Abstract

This case study focuses on a 30-year-old male patient suffering from decompensated liver failure and acute renal failure, complicated by chronic hepatitis B (HBV), hepatitis C (HCV), and HIV/AIDS. Presenting with severe abdominal pain, nausea, and general weakness, the patient had a history of alcohol and intravenous drug use, leading to chronic liver disease and acute renal failure. Despite aggressive interventions, including intravenous antibiotics and fluid therapy, his condition worsened rapidly, leading to his transfer to the ICU and eventual death. The case emphasizes the complex interplay between HBV, HCV, and HIV infections. The patient’s liver failure, compounded by hepatorenal syndrome—a functional renal impairment commonly seen in advanced liver disease—created significant clinical challenges. Furthermore, HIV’s immunosuppressive effects accelerated liver disease progression and complicated management due to potential drug interactions. Key laboratory findings included elevated liver enzymes, indicating significant liver damage, and severe anemia, likely worsened by gastrointestinal bleeding due to portal hypertension. Kidney function was severely impaired, as reflected by elevated serum creatinine and blood urea nitrogen levels, alongside hyperkalemia. This report highlights the critical need for a multidisciplinary approach involving hepatologists, nephrologists, infectious disease specialists, and critical care teams in managing patients with multiple chronic infections. The patient’s rapid deterioration underscores the importance of early diagnosis, aggressive treatment, and comprehensive care plans tailored to the complex needs of such high-risk individuals to improve outcomes.

Keywords: Acquired immunodeficiency syndrome (AIDS), Human immunodeficiency virus (HIV), Hepatitis A, Hepatitis B, Diagnosis

[This article belongs to International Journal of Pathogens ]

How to cite this article:
Devesh Sharma, Saumya Singh, Brijnandan Singh, Nandlal kumar, Rajan pathak. Decompensated Liver Failure and Acute Renal Failure in a Patient with Chronic HBV,HCV, and HIV Infections. International Journal of Pathogens. 2024; 02(01):17-23.
How to cite this URL:
Devesh Sharma, Saumya Singh, Brijnandan Singh, Nandlal kumar, Rajan pathak. Decompensated Liver Failure and Acute Renal Failure in a Patient with Chronic HBV,HCV, and HIV Infections. International Journal of Pathogens. 2024; 02(01):17-23. Available from: https://journals.stmjournals.com/ijpg/article=2024/view=198372


References

  1. Gish RG, Given BD, Lai CL, Locarnini SA, Lau JY, Lewis DL, et al. Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities. Antivir Res. 2015 Sep 1;121:47–58.
  2. Pawlotsky JM. Current and future concepts in hepatitis C therapy. In Seminars in liver disease. , 333 Seventh Avenue, New York, NY 10001: Copyright© 2005 by Thieme Medical Publishers; USA. 2005 Feb;25(01):72–83.
  3. Buell KG, Chung C, Chaudhry Z, Puri A, Nawab K, Ravindran RP. Lifelong antiretroviral therapy or HIV cure: The benefits for the individual patient. AIDS care. 2016 Feb 1;28(2):242–6.
  4. Taylor LE, Swan T, Mayer KH. HIV coinfection with hepatitis C virus: Evolving epidemiology and treatment paradigms. Clin Infect Dis. 2012 Jul 15;55(suppl_1):S33–42.
  5. Seto WK, Lo YR, Pawlotsky JM, Yuen MF. Chronic hepatitis B virus infection. The Lancet. 2018 Nov 24;392(10161):2313–24.
  6. Sarin SK, Choudhury A. Acute-on-chronic liver failure. Curr. Gastroenterol. Rep. 2016 Dec;18:1–6.
  7. Roche B, Samuel D. The difficulties of managing severe hepatitis B virus reactivation. Liver Int. 2011 Jan;31:104–10.
  8. Xu HQ, Wang CG, Zhou Q, Gao YH. Effects of alcohol consumption on viral hepatitis B and C. World J Clin Cases. 2021 Nov 11;9(33):10052.
  9. Bunchorntavakul C, Maneerattanaporn M, Chavalitdhamrong D. Management of patients with hepatitis C infection and renal disease. World J Hepatol. 2015 Feb 2;7(2):213.
  10. Soriano V, Barreiro P, Nunez M. Management of chronic hepatitis B and C in HIV-coinfected patients. J Antimicrob Chemother. 2006 May 1;57(5):815–8.
  11. Weinbaum CM, Sabin KM, Santibanez SS. Hepatitis B, hepatitis C, and HIV in correctional populations: A review of epidemiology and prevention. Aids. 2005 Oct 1;19:S41–6.
  12. Trépo C, Chan HL, Lok A. Hepatitis B virus infection. The Lancet. 2014 Dec 6;384(9959):2053–63.
  13. Sharma SA, Feld JJ. Acute hepatitis C: Management in the rapidly evolving world of HCV. Curr Gastroenterol Rep. 2014 Feb;16:1–
  14. Kwon H, Lok AS. Hepatitis B therapy. Rev. Gastroenterol. Hepatol. 2011 May;8(5):275–84.
  15. Machado MV. MASLD treatment–a shift in the paradigm is imminent. Front Med. 2023 Dec 11;10:1316284.
  16. World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. World Health Organ. 2022 Jul 18.
  17. Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, et al. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection. Hepatol. 2005 Jan;41(1):123–31.
  18. Terrault N. Liver transplantation in the setting of chronic HCV. Best Pract & Res Clin Gastroenterol. 2012 Aug 1;26(4):531–48.
  19. Norris S, Taylor C, Muiesan P, Portmann BC, Knisely AS, Bowles M, et al. Outcomes of liver transplantation in HIV‐infected individuals: The impact of HCV and HBV infection. Liver Transplant. 2004 Oct;10(10):1271–8.
  20. Hughes CA, Tseng A, Cooper R. Managing drug interactions in HIV-infected adults with comorbid illness. Cmaj. 2015 Jan 6;187(1):36–43.
  21. AIDSinfo A. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2013.
  22. Bostan N, Mahmood T. An overview about hepatitis C: A devastating virus. Rev. Microbiol. 2010 May 1;36(2):91–133.
  23. Duraisamy GS, Bhosale D, Lipenská I, Huvarova I, Růžek D, Windisch MP, et al. Advanced therapeutics, vaccinations, and precision medicine in the treatment and management of chronic hepatitis b viral infections; where are we and where are we going? Viruses. 2020 Sep 7;12(9):998.
  24. Betrosian AP, Agarwal B, Douzinas EE. Acute renal dysfunction in liver diseases. World J Gastroenterol: WJG. 2007 Nov 11;13(42):5552.
  25. Kish T, Aziz A, Sorio M. Hepatitis C in a new era: A review of current therapies. Pharm Ther. 2017 May;42(5):316.
  26. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: A global overview. Clin Liver Dis. 2010 Feb 1;14(1):1–21.
  27. Barreiro P, Vispo E, Labarga P, Soriano V. Management and treatment of chronic hepatitis C in HIV patients. In Seminars in liver disease. Thieme Medical Publishers. 2012 May;32(02):138–146.
  28. Soriano V, Barreiro P, Nunez M. Management of chronic hepatitis B and C in HIV-coinfected patients. J Antimicrob Chemother. 2006 May1;57(5):815–8.
  29. Mavilia MG, Wu GY. HBV-HCV coinfection: Viral interactions, management, and viral reactivation. J Clin Transl Hepatol. 2018 Sep 9;6(3):296.
Regular Issue Subscription Case Study
Volume 02
Issue 01
Received 30/09/2024
Accepted 18/10/2024
Published 11/12/2024
Publication Time 72 Days
231

Login


My IP

PlumX Metrics